Kerentech participates at Bioinvestor Day Galicia 2013

October 3, 2013
Congresses

Founded in 2004 in Barcelona, Kerentech pioneers transformative solutions for global biotech and medtech ventures. With a proven track record facilitating investments up to 60M euros, our strategic approach combines deep market knowledge, an extensive network, and authentic collaborations. We specialize in consulting services for biotech companies, driving innovation and success.

Have Any Question?

We are here to help. Feel free to contact us now and we’ll respond as soon as possible.

News & Updates

Cell and Life Therapeutics announces that Prof.Ankur Jain in MIT Biology Dept., joins the Company as CSO and the opening of its US company.

EmstoPA has received the Regulatory Endorsement of Development Program by British MHRA

Our client BrainEver Receives FDA Orphan Drug Designation for BREN-02, (human recombinant Engrailed 1) for the Treatment of Amyotrophic Lateral Sclerosis (ALS)